
Atrix helps medical affairs teams turn messy data and research into actionable insights with automated workflows -- powered by AI. Streamline your team’s workflow, data analysis, and research -- no code, engineers, or data scientists required. Whether it’s 3 steps or 100... Whether it's analyzing field medical notes or generating a systematic literature review... No matter your workflow, you can build it in Atrix. Built with life sciences in mind -- and only for the life sciences. It's as easy as 3 steps: 1/ Grab data from virtually any source 2/ Clean, transform, and enrich your data with an ease of a spreadsheet, backed by the power of AI. We make AI as easy as an excel formula. 3/ Synthesize your insights (whether data or research) in live applications from dashboards, to reports, to summaries ready to share with the team Finally, a tool that fits your team's workflow just right.

Atrix helps medical affairs teams turn messy data and research into actionable insights with automated workflows -- powered by AI. Streamline your team’s workflow, data analysis, and research -- no code, engineers, or data scientists required. Whether it’s 3 steps or 100... Whether it's analyzing field medical notes or generating a systematic literature review... No matter your workflow, you can build it in Atrix. Built with life sciences in mind -- and only for the life sciences. It's as easy as 3 steps: 1/ Grab data from virtually any source 2/ Clean, transform, and enrich your data with an ease of a spreadsheet, backed by the power of AI. We make AI as easy as an excel formula. 3/ Synthesize your insights (whether data or research) in live applications from dashboards, to reports, to summaries ready to share with the team Finally, a tool that fits your team's workflow just right.
Industry: Life sciences / medical affairs AI SaaS
Founded: 2023
Headcount (reported): 8
Funding stage: Seed (multiple early rounds reported)
Notable investors: Bling Capital; Precursor Ventures
Medical affairs and life-sciences commercialization — synthesizing unstructured research, field notes, and data into actionable insights and compliant GTM workflows.
2023
Life sciences; medical affairs software; AI SaaS
Crunchbase reports a Seed round closed on March 31, 2025 with six investors (Bling Capital and Precursor Ventures named among them).
“Early-stage venture backing (includes Bling Capital, Precursor Ventures, Pear, Twine Ventures per profiles)”
| Company |
|---|